Jonathan Sheena sold $1.0M of NTRA
director, other at Natera, Inc.. 6,070 shares at an average of $165.93, traded Jun 16, 2025, filed Jun 20, 2025.
Score components
- +15RoleDirector
- +25Trade size$1.0M at market
- +5Share of holdings soldSold 16% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-017917, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 18, 2025 | SOpen-market sale Common Stock10b5-1 | -3,070 | $167.29 | $514k | 248,774 | Jun 20, 2025 |
| Jun 16, 2025 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -200 | $162.50 | $32k | 38,582 | Jun 20, 2025 |
| Jun 16, 2025 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -203 | $163.41 | $33k | 38,379 | Jun 20, 2025 |
| Jun 16, 2025 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -550 | $164.81 | $91k | 37,829 | Jun 20, 2025 |
| Jun 16, 2025 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -547 | $165.48 | $91k | 37,282 | Jun 20, 2025 |
| Jun 16, 2025 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -176 | $162.52 | $29k | 38,606 | Jun 20, 2025 |
| Jun 16, 2025 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -200 | $163.10 | $33k | 38,406 | Jun 20, 2025 |
| Jun 16, 2025 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -425 | $164.64 | $70k | 37,981 | Jun 20, 2025 |
| Jun 16, 2025 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -699 | $165.41 | $116k | 37,282 | Jun 20, 2025 |
Related signals
Other insiders at Natera, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Natera, Inc. | Steven Leonard Chapman CEO AND PRESIDENT | $526k 1,273 shares | -1% | |
| 40Moderate | Natera, Inc. | Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS | $1.2M 3,000 shares | -3% | |
| 55Moderate | Natera, Inc. | Jonathan Sheena director, other | $7.0M 18,064 shares | -100% | |
| 35Weak | Natera, Inc. | Jonathan Sheena director, other | $3.2M 9,150 shares | -4% | |
| 40Moderate | Natera, Inc. | Matthew Rabinowitz EXECUTIVE CHAIRMAN | $35M 102,000 shares | -5% | |
| 40Moderate | Natera, Inc. | Matthew Rabinowitz EXECUTIVE CHAIRMAN | $16M 50,000 shares | -2% | |
| 39Weak | Natera, Inc. | Steven Leonard Chapman CEO AND PRESIDENT | $545k 1,698 shares | -2% | |
| 45Moderate | Natera, Inc. | Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS | $5.9M 18,160 shares | -14% | |
| 80Strong | Natera, Inc. | Matthew Rabinowitz EXECUTIVE CHAIRMAN | $8.4M 54,000 shares | -64% | |
| 40Moderate | Natera, Inc. | Gail Boxer Marcus director | $658k 4,000 shares | -41% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.